Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Balchem Corporation (BCPC:NASDAQ), powered by AI.
Balchem Corporation is currently trading at $165.04. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Balchem Corporation on Alpha Lenz.
Balchem Corporation's P/E ratio is 34.2.
“Balchem Corporation trades at a P/E of 34.2 (premium valuation) with solid ROE of 12.9%. Operating margin of 20.2% indicates strong profitability.”
Ask for details →Balchem Corporation is a leading producer of specialty performance ingredients and products for the health and wellness sectors. The company specializes in microencapsulation, chelated minerals, and a range of health-focused nutritional products. Through its diverse portfolio, Balchem plays a crucial role in enhancing food and beverage nutrition, improving feed manufacturers' solutions, and providing human-grade nutritional products. The company's operations are divided into segments, including Human Nutrition & Health, Animal Nutrition & Health, Specialty Products, and Industrial Products, each contributing to various industries from agriculture to pharmaceuticals. With a commitment to sustainability and innovation, Balchem continuously adapts to nutritional science advancements and regulatory requirements, making it a significant player in its markets. Its dedication to research and development helps address the modern challenges of health and environmental safety, showcasing its strategic importance in the industry. Based in New Hampton, New York, Balchem Corporation not only impacts its sectors through pioneering technologies but also ensures a sustainable approach towards healthier living.
“Balchem Corporation trades at a P/E of 34.2 (premium valuation) with solid ROE of 12.9%. Operating margin of 20.2% indicates strong profitability.”
Ask for details →Balchem Corporation (ticker: BCPC) is a company listed on NASDAQ in the Basic Materials sector (Specialty Chemicals). It has approximately 1,364 employees. Market cap is $5.3B.
The current price is $165.04 with a P/E ratio of 34.17x and P/B of 4.21x.
ROE is 12.86% and operating margin is 20.18%. Annual revenue is $1.0B.